top of page
Chairman of Kinled Holding, serial entrepreneur who has invested in the life science industry since 1997. Focus on biomedical technology companies developing medical devices, biopharmaceuticals, and healthcare services, with direct investments in over 50 businesses, 24 exiting via IPO, trade sale or licensing.
Director of Aleva Neurotherapeutics SA, PreComb Therapeutics AG, has identified and invested in early-stage spin-off opportunities from Universities in Barcelona, Zurich, Oxford, Boston, Stanford, NorthEastern, Texas, NYU, Lausanne and Geneva.
bottom of page